In a major healthcare-focused announcement under Budget 2026–27, […]
Read More
The global pharmaceutical ecosystem is undergoing a major transformation as governments reassess their dependence o […]
Read More
In today’s competitive pharmaceutical landscape, entrepreneurs are increasingly looking for business models that […]
Read More
Global immunisation efforts are facing renewed scrutiny as funding conditions increasingly influence public health […]
Read More
As India sets its sights on emerging as a global biopharmaceutical leader […]
Read More
The evolving pharma trading relationship between India and Europe […]
Read More
In a significant policy move aimed at simplifying drug development and easing regulatory pressure, the Union Health […]
Read More
Antimicrobial Resistance (AMR) has emerged as one of the most serious public health threats in India. To address th […]
Read More
Artificial Intelligence (AI) is steadily redefining how the pharmaceutical industry operates. While the promise of […]
Read More
Regulatory speed and patient safety often exist in delicate balance, especially when new drug approval programs prom […]
Read More